# Powdered Intrawound Vancomycin in Open Fractures Trial

> **NCT06504992** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Manitoba** · enrollment: 350 (estimated)

## Conditions studied

- Open Fracture
- Trauma
- Infection, Surgical Site
- Fractures, Open
- Wound Infection
- Fractures, Bone
- Post-Operative Wound Infection

## Interventions

- **DRUG:** Vancomycin 1000 MG

## Key facts

- **NCT ID:** NCT06504992
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06504992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06504992, "Powdered Intrawound Vancomycin in Open Fractures Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06504992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*